Group One Trading, L.P. Liva Nova PLC Transaction History

Group One Trading, L.P.

$2.68 Billion
Q1 2024

A detailed history of Group One Trading, L.P. transactions in Liva Nova PLC stock. As of the latest transaction made, Group One Trading, L.P. holds 75 shares of LIVN stock, worth $3,966. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Holding current value

$3,966

% of portfolio

0.0%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$48.6 - $57.12 $3,645 - $4,284	75 New	75 $4,000
Q3 2023 Nov 09, 2023	BUY	$50.12 - $58.87 $510,271 - $599,355	10,181 New	10,181 $538,000
Q3 2022 Nov 09, 2022	BUY	$48.37 - $66.5 $234,014 - $321,727	4,838 Added 338.8%	6,266 $318,000
Q2 2022 Aug 11, 2022	BUY	$57.25 - $86.63 $81,753 - $123,707	1,428 New	1,428 $89,000
Q4 2021 Feb 11, 2022	SELL	$76.72 - $92.68 $15,190 - $18,350	-198 Closed	0 $0

Q3 2021 Nov 12, 2021	BUY	$76.02 - $88.62 $15,051 - $17,546	198 New	198 $16,000
Q2 2020 Aug 13, 2020	SELL	$39.87 - $56.9 $12,040 - $17,183	-302 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$34.22 - $76.49 $10,334 - $23,099	302 New	302 $14,000
Q1 2019 May 13, 2019	SELL	$86.15 - $100.49 $81,497 - $95,063	-946 Closed	0 $0
Q4 2018 Feb 06, 2019	BUY	$84.14 - $125.42 $79,596 - $118,647	946 New	946 $87,000

Others Institutions Holding LIVN

# of Institutions

252

Shares Held

56.2M

Call Options Held

367K

Put Options Held

597K

Black Rock Inc. New York, NY

7.35M
Shares

$389 Million
0.01% of portfolio
Primecap Management CO Pasadena, CA

5.94M
Shares

$314 Million
0.25% of portfolio
Barrow Hanley Mewhinney & Strauss LLC Dallas, TX

2.36M
Shares

$125 Million
0.47% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

2.28M
Shares

$121 Million
0.06% of portfolio
State Street Corp Boston, MA

2M
Shares

$106 Million
0.01% of portfolio

View Full List

About LivaNova PLC

Ticker LIVN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 53,545,700
Market Cap $2.83B
Description
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...

More about LIVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account